IPX IPERIONX Ltd IFRS Annual reports only
Miscellaneous Metal Ores · Nasdaq · SEC CIK 1898601 · Fiscal year ends 06/30
Financial factors as of 2025-06-30 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 | FY20212021-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| R&D expense | $12.75M | $8.71M | $5.60M | $1.08M | $240,000 |
| SG&A expense | $10.69M | $4.52M | $3.99M | $3.06M | $852,944 |
| Interest expense | $279,541 | $122,736 | $88,138 | $45,541 | $3,097 |
| Pretax income | -$35.35M | -$21.84M | -$17.44M | -$21.52M | -$13.23M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$35.35M | -$21.84M | -$17.44M | -$21.52M | -$13.23M |
| EPS (basic) | -0.12 | -0.10 | -0.11 | -0.16 | -0.19 |
| EPS (diluted) | -0.12 | -0.10 | -0.11 | -0.16 | -0.19 |
| Weighted avg. shares (diluted) | 296.89M | 217.84M | 168.03M | 134.61M | 68.80M |
| Balance sheet | |||||
| Cash & equivalents | $54.81M | $33.16M | $11.94M | $5.67M | $1.70M |
| Receivables | $823,268 | $2.30M | $228,395 | $22,540 | $341 |
| Inventory | $0 | $16,920 | $0 | — | — |
| Current assets | $58.88M | $41.55M | $12.75M | $5.84M | $1.75M |
| PP&E, netmay include right-of-use assets (IFRS) | $25.20M | $7.77M | $3.99M | $1.39M | $539,619 |
| Intangibles | $13.55M | $0 | — | — | — |
| Total assets | $105.03M | $55.44M | $22.80M | $9.91M | $2.79M |
| Current liabilities | $8.43M | $3.05M | $1.65M | $2.08M | $637,015 |
| Short-term debt | $472,018 | $445,755 | $382,626 | $134,247 | $81,104 |
| Long-term debt | $3.46M | $1.04M | $592,688 | $408,783 | $394,548 |
| Total debt | $3.93M | $1.49M | $975,314 | $543,030 | $475,652 |
| Total liabilities | $12.59M | $4.10M | $2.24M | $2.49M | $1.03M |
| Shareholders' equity | $92.44M | $51.34M | $20.56M | $7.42M | $1.76M |
| Net debt | -$50.88M | -$31.67M | -$10.96M | -$5.13M | -$1.22M |
| Cash flow statement | |||||
| Operating cash flow | -$21.80M | -$18.61M | -$15.86M | -$12.13M | -$3.56M |
| Capital expenditure | $16.96M | $5.02M | $2.08M | $889,988 | $66,818 |
| Free cash flow | -$38.76M | -$23.63M | -$17.94M | -$13.02M | -$3.62M |
| Investing cash flow | -$24.28M | -$6.53M | -$5.71M | -$3.07M | -$571,568 |
| Financing cash flow | $67.99M | $46.59M | $27.89M | $19.39M | $5.83M |
| Depreciation & amortization | — | $645,851 | $426,534 | $153,434 | $9,324 |
| Stock-based compensation | $9.57M | $3.79M | $2.59M | $8.34M | $4.08M |
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.